AumniVIDA

What does a high hs-CRP mean?

Updated October 31, 2026 · 18 sources · Written by the AumniVIDA team

Units

Short answer

A high hs-CRP means more inflammation than average. Between 3 and 10 mg/L (0.3 to 1.0 mg/dL) it marks higher relative heart risk, about twice the lowest group. Over 10 mg/L usually points to infection, injury or another inflammatory cause, so guidelines advise looking for it and repeating the test in about 2 weeks.

What raises hs-CRP, and by how much

Acute: often over 10 mg/L

Rises within hours, settles within days.

  • Bacterial infection
  • Injury or surgery
  • Severe cases can exceed 500 mg/L

Short-term rise

A significant rise for a few days.

  • Marathon or very hard endurance effort: still raised after 3 days

Chronic: shifts the baseline

Fractions of a mg/L to a few mg/L.

  • Obesity: about 6 times the odds of 2.2 mg/L or more in women, 2 times in men
  • Smoking: dose related, raised up to 5 years after quitting
  • Chronic inflammatory disease or chronic infection, such as gum disease
  • Estrogen or progestogen use
  • Metabolic syndrome, diabetes, high blood pressure
  • Disturbed or very long sleep: small effect
  • Female sex: median 3.3 versus 1.8 mg/L

What lowers it

Slower changes in the baseline.

  • Weight loss
  • Mediterranean diet
  • Regular exercise
  • Not smoking
  • Statins

Causes overlap: smokers and people with diabetes are often also heavier. A heart-risk reading only counts when nothing acute is going on.

Infection and injury push CRP into the tens or hundreds of mg/L; body fat, smoking, chronic inflammatory disease and hormones shift the baseline by a few mg/L.

Key takeaways

  1. 1

    Over 3 mg/L is the higher relative risk category; 2 mg/L or more is a risk-enhancing factor in US guidelines [1] [2].

  2. 2

    Over 10 mg/L usually reflects an infection, injury or inflammatory disease, not heart risk; repeat the test in about 2 weeks [1].

  3. 3

    A persistently unexplained value over 10 mg/L after repeat testing should be evaluated for noncardiovascular causes [1].

  4. 4

    Body fat, smoking, hard endurance exercise, hormone therapy and chronic disease are the common everyday causes [3] [4] [5].

What counts as a high hs-CRP?

For heart risk, over 3 mg/L (0.3 mg/dL) is high and 2 mg/L (0.2 mg/dL) or more is a risk-enhancing factor. Over 10 mg/L (1.0 mg/dL) is a different signal: usually an acute or chronic inflammatory cause.

The CDC/AHA statement set three relative risk groups: under 1 mg/L, 1 to 3 mg/L and over 3 mg/L. People in the top group had about twice the relative risk of the bottom group [1]. The 2018 AHA/ACC cholesterol guideline uses 2.0 mg/L or more as one of several risk-enhancing factors [2], the same entry level used in the JUPITER and CANTOS trials [6] [7].

hs-CRPIn mg/dLWhat it usually means
Under 1 mg/LUnder 0.1Lower relative risk
1 to 3 mg/L0.1 to 0.3Average relative risk
Over 3 to 10 mg/L0.3 to 1.0Higher relative risk, if you are well
Over 10 mg/LOver 1.0Look for infection or inflammation and repeat

A high result is a relative risk signal. It means most when read with the rest of the picture: blood pressure, smoking, diabetes, ApoB or LDL cholesterol and lipoprotein(a).

hs-CRP categories in mg/L

AverageHigher relative riskLower relative risk: 0 to 1 mg/LLower relative risk: 0 to 1 mg/LLower relative risk: 0 to 1 mg/LLower relative risk: 0 to 1 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LLower relative risk: 0 to 1 mg/LLower relative risk: 0 to 1 mg/LLower relative risk: 0 to 1 mg/LLower relative risk: 0 to 1 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LAverage: 1 to 3 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LHigher relative risk: 3 to 10 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/LRepeat and look for another cause: 10 to 12 mg/L01CDC/AHA low cut point: 1 mg/L2Risk-enhancing factor; JUPITER and CANTOS entry: 2 mg/L3CDC/AHA high cut point: 3 mg/L10Repeat in about 2 weeks: 10 mg/L12 mg/L
Lower relative risk
0 to 1
Average
1 to 3
Higher relative risk
3 to 10
Repeat and look for another cause
10 to 12
  • 1 mg/L: CDC/AHA low cut point
  • 2 mg/L: Risk-enhancing factor; JUPITER and CANTOS entry
  • 3 mg/L: CDC/AHA high cut point
  • 10 mg/L: Repeat in about 2 weeks
Under 1 mg/L is lower relative risk, 1 to 3 mg/L average and over 3 mg/L higher; a result over 10 mg/L usually means something else is going on and should be repeated.

What does an hs-CRP over 10 mg/L mean?

A result over 10 mg/L (1.0 mg/dL) usually means an infection, injury or inflammatory flare is raising CRP, which hides any heart-risk signal. The CDC/AHA advice is to look for the cause, discard the value and test again in about 2 weeks.

More than 95% of people in most populations have an hs-CRP under 10 mg/L [1], so a value above it stands out. CRP rises above 10 mg/L in most acute infections, inflammatory conditions and trauma [8], and in severe cases it can pass 500 mg/L [9].

The 2003 guidance is specific [1]:

  1. Look for an obvious source of infection or inflammation.
  2. Discard the result for heart-risk purposes.
  3. Repeat the test in about 2 weeks, once acute inflammation has settled.
  4. If the value stays over 10 mg/L without an explanation, evaluate for noncardiovascular causes.

Two weeks is enough because CRP has a half-life of about 19 hours. Once the trigger ends, the liver stops making extra CRP and the level falls within days [9].

How an infection spikes CRP and how long it takes to settle

  1. Rise
  2. Hour 0Trigger: infection, injury or surgeryThe liver starts making extra CRP.
  3. About 6 hoursCRP passes 5 mg/L
  4. About 48 hoursCRP peaksSevere infection or trauma can push it past 500 mg/L.
  5. Settle
  6. Days afterCRP falls once the trigger endsIts half-life is about 19 hours, so the level drops within days.
  7. About 2 weeksRetest windowIf a result was over 10 mg/L, repeat the test now (CDC/AHA 2003).

A marathon gives a smaller rise: CRP peaked the next day and was still raised 3 days later (Takayama 2018). Timings are typical averages (Pepys 2003).

CRP passes 5 mg/L about 6 hours after a trigger, peaks around 48 hours and, with a half-life near 19 hours, falls back once the trigger ends; that is why a result over 10 mg/L is repeated after about 2 weeks.

What are the common causes of a high hs-CRP?

The everyday causes are recent infection or injury, excess body fat, smoking, a very hard endurance effort, hormone therapy and chronic inflammatory or metabolic disease. Women also have higher levels than men on average.

CauseTypical sizeSource
Recent infection, injury, surgeryOften over 10 mg/L, sometimes over 500 mg/L[9] [8]
Marathon or similar effortPeaks the next day, raised for about 3 days[5]
ObesityAbout 2 times (men) to 6 times (women) the odds of CRP 2.2 mg/L or more[3]
SmokingRises with pack-years; raised up to 5 years after quitting[4]
Rheumatoid arthritis, gum disease, bronchitisRaised while active[1]
Estrogen or progestogen therapyRaised[1]
Metabolic syndrome, diabetes, high blood pressureRaised[1]
Female sexMedian 3.3 versus 1.8 mg/L in men[10]

The full table, with how long each effect lasts, is on the hs-CRP hub. Insulin resistance often travels with a raised hs-CRP, so fasting insulin and HbA1c can help explain a high value.

What should you do if your hs-CRP is high?

Check the result was taken while you were well, repeat it about 2 weeks later and average the two. If it stays above 2 to 3 mg/L, discuss it with a clinician as part of your overall heart risk, and work on the levers that lower it.

A practical sequence, based on the CDC/AHA advice [1]:

  1. Think back over the past two weeks. A cold, a dental problem, a hard race or a minor injury can all raise CRP.
  2. Repeat the test while well. Average two results about 2 weeks apart. Single values vary by about 42% within a person [11].
  3. Read it with your other numbers. hs-CRP adds most for people at intermediate risk [1]. A clinician will look at LDL cholesterol or ApoB, Lp(a), blood pressure, glucose and family history.
  4. Work on the levers. Weight loss, a Mediterranean-style diet, regular exercise and not smoking all lower hs-CRP. The sizes are on how to lower hs-CRP.
  5. Leave medicine choices to your clinician. In JUPITER, people with hs-CRP of 2 mg/L or more and normal LDL had fewer events on a statin [6]; colchicine is used in people with established coronary disease [12].

This page explains the evidence. It is not a substitute for advice from someone who knows your history.

When is a high CRP a red flag?

A value over 10 mg/L that stays high on repeat testing with no clear cause needs a medical evaluation. Any high CRP together with fever, unexplained weight loss, night sweats, new joint swelling or severe pain also warrants prompt attention.

The CDC/AHA statement rates evaluation of persistently unexplained values over 10 mg/L as a class IIa recommendation [1]. Signs that make a medical review more urgent:

  • Fever, chills or feeling acutely unwell.
  • Unexplained weight loss or drenching night sweats.
  • New swollen, hot or stiff joints, or a new rash.
  • Persistent cough, abdominal pain or urinary symptoms.
  • Chest pain or shortness of breath, which need emergency care whatever the CRP.

None of these is diagnosed by CRP. CRP only says that inflammation is present; it cannot say where [13].

Does a high hs-CRP mean you will have a heart attack?

No. A high hs-CRP raises the odds but does not predict an individual event. In healthy men, the top quarter of CRP had about three times the heart attack risk of the bottom quarter, and most people in that top quarter still had no event.

Relative risks for hs-CRP are real but moderate. In healthy men the top versus bottom quarter carried a relative risk of 2.9 for heart attack [14]. In pooled data, each threefold higher CRP raised coronary risk by 37% after adjusting for other risk factors [13]. Adding CRP to a standard risk model improves prediction only slightly [15].

Genetic evidence also suggests CRP is a messenger rather than a cause [16]. Lowering the inflammation behind it, with lifestyle or with medicines your clinician chooses, is what has changed outcomes in trials [7] [12].

More about hs-CRP

Protocols that act on hs-CRP

Common questions

Is an hs-CRP of 5 mg/L bad?

If you were well when tested, 5 mg/L (0.5 mg/dL) is in the higher relative risk group, over 3 mg/L [1]. Repeat it after about 2 weeks and average the two before drawing conclusions.

Can stress raise hs-CRP?

Indirectly. Disturbed sleep, which often comes with stress, is linked to slightly higher CRP [17]. Short-term stress on its own has not been shown to push hs-CRP into the high range in the sources we reviewed.

Can a cold raise hs-CRP?

Yes. Any infection can raise CRP, and the level falls once the infection ends because of its 19 hour half-life [9]. That is why guidelines advise testing only when you are well [1].

Can exercise raise hs-CRP?

A single very hard effort can. After a marathon, CRP peaked the next day and stayed raised for 3 days [5]. Regular training lowers it over months [18].

Is high hs-CRP treated?

The number itself is not treated; the risk and its causes are. Lifestyle change lowers it, and clinicians may use statins or, in established coronary disease, colchicine [6] [12].

Sources

  1. 1.Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003. doi:10.1161/01.cir.0000052939.59093.45
  2. 2.Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2019. doi:10.1161/CIR.0000000000000625
  3. 3.Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA, 1999. doi:10.1001/jama.282.22.2131
  4. 4.Hastie CE, Haw S, Pell JP. Impact of smoking cessation and lifetime exposure on C-reactive protein. Nicotine & Tobacco Research, 2008. doi:10.1080/14622200801978722
  5. 5.Takayama F, Aoyagi A, Takahashi K, Nabekura Y. Relationship between oxygen cost and C-reactive protein response to marathon running in college recreational runners. Open Access Journal of Sports Medicine, 2018. doi:10.2147/OAJSM.S183274
  6. 6.Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine, 2008. doi:10.1056/NEJMoa0807646
  7. 7.Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine, 2017. doi:10.1056/NEJMoa1707914
  8. 8.Kamath DY, Xavier D, Sigamani A, Pais P. High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective. Indian Journal of Medical Research, 2015. doi:10.4103/0971-5916.166582
  9. 9.Pepys MB, Hirschfield GM. C-reactive protein: a critical update. Journal of Clinical Investigation, 2003. doi:10.1172/JCI18921
  10. 10.Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. Journal of the American College of Cardiology, 2005. doi:10.1016/j.jacc.2005.04.051
  11. 11.Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clinical Chemistry, 1997. PubMed 8990222
  12. 12.Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in Patients with Chronic Coronary Disease. New England Journal of Medicine, 2020. doi:10.1056/NEJMoa2021372
  13. 13.Emerging Risk Factors Collaboration; Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 2010. doi:10.1016/S0140-6736(09)61717-7
  14. 14.Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 1997. doi:10.1056/NEJM199704033361401
  15. 15.Emerging Risk Factors Collaboration; Kaptoge S, Di Angelantonio E, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. New England Journal of Medicine, 2012. doi:10.1056/NEJMoa1107477
  16. 16.C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC); Wensley F, Gao P, et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ, 2011. doi:10.1136/bmj.d548
  17. 17.Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biological Psychiatry, 2016. doi:10.1016/j.biopsych.2015.05.014
  18. 18.Fedewa MV, Hathaway ED, Ward-Ritacco CL. Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials. British Journal of Sports Medicine, 2017. doi:10.1136/bjsports-2016-095999

AumniVIDA explains health data for general wellness. Talk to your clinician about your own results, medication and diagnosis.

Track your hs-CRP over time.

Bring every lab report into one history, compare results with your own baseline, and ask the coach what changed. Join the iPhone beta.

Join the iPhone beta. We send TestFlight invitations in batches.